相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Michael H. Le et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis
Kaneez Fatima et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)
Treatments for NAFLD: State of Art
Alessandro Mantovani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis
Georgios Kalopitas et al.
NUTRITION (2021)
Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
Gang Tang et al.
PHYTOTHERAPY RESEARCH (2021)
Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases
Lara Testai et al.
NUTRIENTS (2021)
Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes: A Network Meta-Analysis
Jingxuan Lian et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
SYSTEMATIC REVIEWS (2021)
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Daniel Ferguson et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
Amelio F. Godoy-Matos et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients
Annalisa Curcio et al.
MEDICINA-LITHUANIA (2020)
Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
Suzanne R. Sharpton et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)
Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials
Iram Amanullah et al.
POSTGRADUATE MEDICAL JOURNAL (2019)
Coenzyme Q10 attenuates high- fat diet- induced non- alcoholic fatty liver disease through activation of the AMPK pathway
Ke Chen et al.
FOOD & FUNCTION (2019)
Coenzyme Q10 serves to couple mitochondrial oxidative phosphorylation and fatty acid β-oxidation, and attenuates NLRP3 inflammasome activation
Suphannee Chokchaiwong et al.
FREE RADICAL RESEARCH (2018)
Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials
Fariborz Mansour-Ghanaei et al.
PHYTOTHERAPY RESEARCH (2018)
Coenzyme Q10 Supplementation in Aging and Disease
Juan D. Hernandez-Camacho et al.
FRONTIERS IN PHYSIOLOGY (2018)
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence
Arrigo F. G. Cicero et al.
NUTRIENTS (2018)
Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review
Susan Kenneally et al.
BMJ OPEN GASTROENTEROLOGY (2017)
Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Farnaz Farsi et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2016)
Effects of coenzyme Q10 supplementation on the anthropometric variables, lipid profiles and liver enzymes in patients with nonalcoholic fatty liver disease
Elnaz Jafarvand et al.
BANGLADESH JOURNAL OF PHARMACOLOGY (2016)
The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and Progression
Kathleen M. Botham et al.
NUTRIENTS (2015)
Oral Coenzyme Q10 Supplementation in Patients with Nonalcoholic Fatty Liver Disease: Effects on Serum Vaspin, Chemerin, Pentraxin 3, Insulin Resistance and Oxidative Stress
Mahdieh Abbasalizad Farhangi et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
Coenzyme Q10 supplementation improves metabolic parameters, liver function and mitochondrial respiration in rats with high doses of atorvastatin and a cholesterol-rich diet
Ma Antonia Jimenez-Santos et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
Howard C. Masuoka et al.
YEAR IN DIABETES AND OBESITY (2013)
The Effect of Co-Enzyme Q10 on Acute Liver Damage in Rats, a Biochemical and Pathological Study
Soheil Ashkani Esfahani et al.
HEPATITIS MONTHLY (2013)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
Elisa Fabbrini et al.
HEPATOLOGY (2010)
Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice
Florence M. Sohet et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-β1 expression
Hoo-Kyun Choi et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Nonalcoholic Fatty Liver Disease: A Review of Current Understanding and Future Impact
Michael Charlton
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
分享论文
